Ixifi 100 mg

Ixifi 100 mg is a medicine authorised by Swissmedic under authorisation number 69721. The authorisation holder is Pfizer AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 September 2025 and the authorisation is limited until 24 September 2030. ATC code L04AB02 places the medicine in the group Immunosuppressants.

  • Dispensing category A
  • Authorisation number 69721
  • ATC L04AB02
  • Biotechnological medicines
Authorisation data
Authorisation number69721
NameIxifi 100 mg
Full nameIxifi 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderPfizer AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL04AB02
First authorisation25 September 2025
Authorisation validity24 September 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Ixifi 100 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA25 September 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AB0207.15.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ixifi 100 mg authorised in Switzerland?

Yes. Ixifi 100 mg is authorised by Swissmedic under authorisation number 69721, data as of 01 September 2026. The authorisation is limited until 24 September 2030.

Which dispensing category does Ixifi 100 mg have?

Ixifi 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Ixifi 100 mg?

The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com